SITC 2026 Dinner Lecture
Integrating 3D pathology with molecular and microenvironment profiling
RSVP for the Dinner LectureJoin Alpenglow Biosciences during SITC 2026 for an evening lecture exploring how 3D pathology can be integrated with molecular analysis and tumor microenvironment profiling.
The discussion will explore emerging approaches for connecting volumetric tissue imaging with molecular and microenvironmental information. Topics will include 3D-guided microdissection and targeted sectioning, the compatibility of 3D pathology workflows with downstream molecular assays, and 3D graph-based approaches for quantifying cellular interactions within the tumor microenvironment.
Together, these approaches point toward a more integrated view of tissue biology, connecting molecular information with cellular neighborhoods, spatial relationships, and tissue architecture in 3D.
Recent related work from Jonathan Liu and collaborators
Read the paper ↗
Read the paper ↗
Read the paper ↗
Read the preprint ↗
Read the paper ↗
Speaker
Jonathan T.C. Liu, PhD
Biomedical Engineer, Professor of Pathology, and Co-founder of Alpenglow Biosciences
Dr. Jonathan Liu is a biomedical engineer and professor of pathology whose research focuses on high-resolution optical imaging, computational analysis, and non-destructive slide-free 3D pathology. His laboratory develops technologies for clinical decision support and surgical guidance, with an emphasis on imaging larger tissue volumes while preserving specimens for downstream molecular analysis.
The Liu lab works across the full 3D pathology workflow, including reversible optical clearing and fluorescence labeling, high-throughput open-top light-sheet microscopy, image processing, and AI-based analysis. The group also develops quantitative methods to study 3D tissue architecture, cellular organization, and spatial relationships, with applications that complement molecular profiling, genomics, and radiomics.
Dr. Liu received his B.S.E. from Princeton University and his M.S. and Ph.D. in mechanical engineering from Stanford University. He is a co-founder and board member of Alpenglow Biosciences, which has commercialized non-destructive 3D pathology technologies developed in his laboratory. His work has been supported by the NCI, NIBIB, NIDDK, Department of Defense, NSF, ARPA-H, and several foundations.
RSVP
RSVP
This is a complimentary event for Pharmaceutical, Biotech, and Academic attendees.
DATE
November 5th, 2026
TIME
06:00 - 8:00 PM
LOCATION
TBD, Phoenix
CONTACT
Steve Pemberton: steve@alpenglowbiosciences.com